Risk Factors for HCV Infection Among Young Adults in
Rural New York Who Inject Prescription Opioid Analgesics.
Zibbell JE,
Hart-Malloy R, Barry J, Fan L, Flanigan C.
Am J Public Health. 2014
Sep 11:e1-e7.
Abstract
FULL-TEXT
ARTICLE
Per-Event
Probability of Hepatitis C Infection during Sharing of Injecting
Equipment.
Boelen L, Teutsch S, Wilson DP, et al
PLoS One. 2014 Jul
7;9(7):e100749
Paper
Can hepatitis C virus infection be eradicated in people who
inject drugs?
Grebely J, Dore GJ.
Antiviral Res. 2014
Jan 24.
Abstract
FULL-TEXT ARTICLE
Hepatitis C transmission and treatment in contact networks of people who inject
drugs.
Rolls DA, Sacks-Davis R, Jenkinson R, et al
PLoS One. 2013 Nov 1;8(11):e78286
Paper
Hepatitis C infection in non-treatment-seeking heroin users: The burden of
cocaine injection.
Roux P, Fugon L, Jones JD, Comer SD.
Am J Addict. 2013
Nov;22(6):613-8.
Abstract
Liver fibrosis progression at autopsy in injecting drug users
infected by hepatitis C: A longitudinal long-term cohort study
Kielland KB, Delaveris GJ, Rogde S, et al
J Hepatol. 2013 Oct 1.
Abstract
Rare occurrence of occult hepatitis C virus in apparently
uninfected injecting drug users: a two-centre, masked, case-control
study.
Sugden PB, Pham TN, Ratnarajah S, et al
J Viral Hepat. 2013
Oct;20(10):725-8.
Abstract
FULL-TEXT ARTICLE
Factors
associated with uptake, adherence, and efficacy of hepatitis C treatment in
people who inject drugs: a literature review
Mravčík V, Strada L, Stolfa J, et al
Patient Prefer Adherence.
2013 Oct 17;7:1067-1075.
Paper
The efficiency of targeted intervention in limiting the spread
of HIV and Hepatitis C Virus among injecting drug users.
De Vos AS, Kretzschmar ME.
J Theor Biol. 2013 May
31.
Abstract
Control over drug acquisition, preparation and injection:
Implications for HIV and HCV risk among young female injection drug
users.
Wagner KD, Bloom JJ, Hathazi SD, et al
ISRN
Addict. 2013 May 12;2013.
Abstract
A time since onset of injection model for hepatitis C spread
amongst injecting drug users.
Corson S, Greenhalgh D, Hutchinson SJ.
J Math Biol. 2012 Aug 28.
Abstract
Hepatitis C virus clearance, reinfection, and persistence, with insights from
studies of injecting
drug users: towards a vaccine.
Grebely J, Prins M, Hellard M,
et al
Lancet Infect Dis. 2012
May;12(5):408-414
Abstract
Spontaneous clearance of primary acute hepatitis C virus infection
correlated with high initial viral RNA
level
and rapid HVR1 evolution.
Liu L, Fisher BE, Thomas DL,
et al
Hepatology. 2012 Jan
11.
Abstract
Meta-Analysis of Hepatitis C Seroconversion in Relation to
Shared Syringes and Drug Preparation Equipment.
Pouget ER, Hagan H, Des Jarlais DC.
Addiction. 2011 Dec 13.
Abstract |
Hepatitis C Transmission in Injection Drug Users: Could Swabs Be
the Main Culprit?
Thibault V, Bara JL, Nefau T, Duplessy-Garson C.
J Infect Dis. 2011 Oct 19
Abstract
Mathematically modelling the spread of hepatitis C in injecting
drug users.
Corson S, Greenhalgh D, Hutchinson S.
Math Med Biol. 2011 Sep 6
Abstract
Low risk for hepatitis C seroconversion in methadone maintenance
treatment.
Peles E, Schreiber S, Rados V, Adelson M.
J Addict Med. 2011
Sep;5(3):214-20.
Abstract
Multicentric Castleman's Disease in a Hepatitis C-Positive
Intravenous Drug User: A Case Report.
Talukder DY, Delpachitra SN.
Case Report Med. 2011;2011:567840.
Abstract
Chronic pain and hepatitis C virus infection in opioid dependent
injection drug users.
Tsui JI, Herman DS, Kettavong M, et al
J Addict Dis. 2011 Apr;30(2):91-7
Abstract
Survival of Hepatitis C Virus in Syringes: Implication for
Transmission among
Injection Drug Users.
Paintsil E, He H, Peters C, et al .
J Infect Dis. 2010 Aug 20
Abstract |